Search This Blog

Sunday, April 28, 2013

Pfizer Presents Phase 3 Safety And Immunogenicity Data On Prevenar 13 In Adults Aged 18 To 49 Years | Pfizer Pharmaceutical News and Media | Pfizer: the world's largest research-based pharmaceutical company

Pfizer Presents Phase 3 Safety And Immunogenicity Data On Prevenar 13 In Adults Aged 18 To 49 Years | Pfizer Pharmaceutical News and Media | Pfizer: the world's largest research-based pharmaceutical company

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.